9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

18F-FSPG PET/CT for Cancer Patients on Therapy

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > 18F-FSPG PET/CT for Cancer Patients on Therapy

18F-FSPG PET/CT for Cancer Patients on Therapy

Estimated reading time: < 1 min

Condition: B-Cell Neoplasm

Estimated Enrollment: 7

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: Has Results

Outcome Measures: Change From Baseline in Standard Uptake Value Maximum (SUVmax) Post-treatment,  Number of Treatment-Related Adverse Events,  Change From Baseline in Lesion Size Post-treatment, by 18F-FSPG or 18F-FDGs,

Interventions: 18F-FSPG, 18F-FDG

Phase:

Study Type: Interventional

Study Design: Intervention Model: Single Group Assignment, Masking: None (Open Label), Primary Purpose: Diagnostic,

Primary Completion Date: December 14, 2016

Completion Date: December 14, 2016

Last  Posted Date: January 3, 2019

Location: Stanford University Medical Center, Stanford, California, United States

Website Link: https://ClinicalTrials.gov/show/NCT02599194

Was this article helpful?
Dislike 0